Journal of Neural Transmission

, 116:1493

Retinopathy in Parkinson disease

Authors

    • NPF Center of Excellence, Department of NeurologySUNY Downstate Medical Center
Basic Neurosciences, Genetics and Immunology - Original Article

DOI: 10.1007/s00702-009-0292-z

Cite this article as:
Bodis-Wollner, I. J Neural Transm (2009) 116: 1493. doi:10.1007/s00702-009-0292-z

Abstract

One of the non-motor manifestations of PD is visual system involvement. Foveal vision is a main contributor to both visual recognition and discrimination and to both overt and covert visual attention. Experimental evidence from humans and monkeys shows that D1 and D2 receptors are essential for retinal ganglion cell receptive field organization. The evidence linking retinopathy and foveal visual impairment in PD is discussed. A model of retinal preganglionic dopaminergic circuitry is presented. Experimental evidence in humans, using Optical Coherence Tomography shows morphological changes of retinal neurons, including ganglion cells in PD. The diagnosis of pre-cardinal stage of PD (PCPD) may take advantage of the wide availability of optical coherence tomography as a potential biomarker. Fourier-domain OCT and visual testing may contribute a quantitative approach to the early diagnosis, the effects of treatment and follow-up of progression of PD.

Keywords

Parkinson diseaseRetinaFoveal visionDopamine receptorsERGPresynaptic cross inhibitory modelOptical coherence tomographyRetinal thinning

Copyright information

© Springer-Verlag 2009